CS logo
small CS logo
Haugesund Sanitetsforenings Revmatismesykehus

Haugesund, Norway
Sykehus i Haugesund

About Haugesund Sanitetsforenings Revmatismesykehus


Haugesund Sanitetsforenings Revmatismesykehus AS er et spesialsykehus for pasienter med revmatiske sykdommer, og for pasienter med ulike typer hudsykdommer. Sykehusets primære oppgave er utredning, behandling, rehabilitering og pleie av pasienter med revmatiske sykdommer og hudsykdommer.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Haugesund Sanitetsforenings Revmatismesykehus


During the past decade, Haugesund Sanitetsforenings Revmatismesykehus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Haugesund Sanitetsforenings Revmatismesykehus" #1 sponsor was "Diakonhjemmet Hospital" with 2 trials, followed by "Haukeland University Hospital" with 2 trials sponsored, "National Resource Center for Rehabilitation in Rheumatology" with 2 trials sponsored, "Espen A. Haavardsholm" with 1 trials sponsored and "Hospital of Southern Norway Trust" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Haugesund Sanitetsforenings Revmatismesykehus" #1 collaborator was "Haugesund Rheumatism Hospital" with 4 trials as a collaborator, "Oslo University Hospital" with 2 trials as a collaborator, "The Research Council of Norway" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Haukeland University Hospital" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

Clinical Trials Conditions at Haugesund Sanitetsforenings Revmatismesykehus


According to Clinical.Site data, the most researched conditions in "Haugesund Sanitetsforenings Revmatismesykehus" are "Rheumatoid Arthritis" (4 trials), "Ankylosing Spondylitis" (2 trials), "Psoriatic Arthritis" (2 trials), "Spondyloarthritis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Haugesund Sanitetsforenings Revmatismesykehus" in a lesser frequency.

Clinical Trials Intervention Types at Haugesund Sanitetsforenings Revmatismesykehus


Most popular intervention types in "Haugesund Sanitetsforenings Revmatismesykehus" are "Procedure" (3 trials), "Device" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Biosimilar infliximab" (1 trials), "Care as usual" (1 trials), "Celecoxib 200 milligrams" (1 trials), "Celecoxib 400 milligrams" (1 trials) and "Computer navigated knee replacement" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Haugesund Sanitetsforenings Revmatismesykehus


The vast majority of trials in "Haugesund Sanitetsforenings Revmatismesykehus" are 10 trials for "All" genders.

Clinical Trials Status at Haugesund Sanitetsforenings Revmatismesykehus


Currently, there are NaN active trials in "Haugesund Sanitetsforenings Revmatismesykehus". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Haugesund Sanitetsforenings Revmatismesykehus, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Haugesund Sanitetsforenings Revmatismesykehus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".